世界の中枢神経系（CNS）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Central Nervous System Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1231 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、中枢神経系（CNS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・中枢神経系（CNS）治療の市場動向 ・企業の競争状況、市場シェア ・中枢神経系（CNS）治療の種類別市場規模（OTC、Rx薬剤） ・中枢神経系（CNS）治療の用途別市場規模（病院、小売薬局） ・中枢神経系（CNS）治療の北米市場規模2016-2027（アメリカ、カナダ） ・中枢神経系（CNS）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・中枢神経系（CNS）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・中枢神経系（CNS）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・中枢神経系（CNS）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biogen、Pfizer、Teva、Novartis、Johnson & Johnson、EliLilly、Otsuka、Merck、AstraZeneca、Novartis、Takeda） ・結論

The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.

Market Analysis and Insights: Global Central Nervous System Treatment Market
The global Central Nervous System Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Central Nervous System Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Central Nervous System Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Central Nervous System Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Central Nervous System Treatment market.

Global Central Nervous System Treatment Scope and Market Size
Central Nervous System Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Central Nervous System Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
OTC
Rx Drugs

Segment by Application
Hospital
Retail Pharmacy

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
EliLilly
Otsuka
Merck
AstraZeneca

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Central Nervous System Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Central Nervous System Treatment Market Perspective (2016-2027)
2.2 Central Nervous System Treatment Growth Trends by Regions
2.2.1 Central Nervous System Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Central Nervous System Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Central Nervous System Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Central Nervous System Treatment Industry Dynamic
2.3.1 Central Nervous System Treatment Market Trends
2.3.2 Central Nervous System Treatment Market Drivers
2.3.3 Central Nervous System Treatment Market Challenges
2.3.4 Central Nervous System Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System Treatment Players by Revenue
3.1.1 Global Top Central Nervous System Treatment Players by Revenue (2016-2021)
3.1.2 Global Central Nervous System Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Central Nervous System Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Central Nervous System Treatment Revenue
3.4 Global Central Nervous System Treatment Market Concentration Ratio
3.4.1 Global Central Nervous System Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System Treatment Revenue in 2020
3.5 Central Nervous System Treatment Key Players Head office and Area Served
3.6 Key Players Central Nervous System Treatment Product Solution and Service
3.7 Date of Enter into Central Nervous System Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Central Nervous System Treatment Breakdown Data by Type
4.1 Global Central Nervous System Treatment Historic Market Size by Type (2016-2021)
4.2 Global Central Nervous System Treatment Forecasted Market Size by Type (2022-2027)

5 Central Nervous System Treatment Breakdown Data by Application
5.1 Global Central Nervous System Treatment Historic Market Size by Application (2016-2021)
5.2 Global Central Nervous System Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Central Nervous System Treatment Market Size (2016-2027)
6.2 North America Central Nervous System Treatment Market Size by Type
6.2.1 North America Central Nervous System Treatment Market Size by Type (2016-2021)
6.2.2 North America Central Nervous System Treatment Market Size by Type (2022-2027)
6.2.3 North America Central Nervous System Treatment Market Size by Type (2016-2027)
6.3 North America Central Nervous System Treatment Market Size by Application
6.3.1 North America Central Nervous System Treatment Market Size by Application (2016-2021)
6.3.2 North America Central Nervous System Treatment Market Size by Application (2022-2027)
6.3.3 North America Central Nervous System Treatment Market Size by Application (2016-2027)
6.4 North America Central Nervous System Treatment Market Size by Country
6.4.1 North America Central Nervous System Treatment Market Size by Country (2016-2021)
6.4.2 North America Central Nervous System Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Central Nervous System Treatment Market Size (2016-2027)
7.2 Europe Central Nervous System Treatment Market Size by Type
7.2.1 Europe Central Nervous System Treatment Market Size by Type (2016-2021)
7.2.2 Europe Central Nervous System Treatment Market Size by Type (2022-2027)
7.2.3 Europe Central Nervous System Treatment Market Size by Type (2016-2027)
7.3 Europe Central Nervous System Treatment Market Size by Application
7.3.1 Europe Central Nervous System Treatment Market Size by Application (2016-2021)
7.3.2 Europe Central Nervous System Treatment Market Size by Application (2022-2027)
7.3.3 Europe Central Nervous System Treatment Market Size by Application (2016-2027)
7.4 Europe Central Nervous System Treatment Market Size by Country
7.4.1 Europe Central Nervous System Treatment Market Size by Country (2016-2021)
7.4.2 Europe Central Nervous System Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System Treatment Market Size (2016-2027)
8.2 Asia-Pacific Central Nervous System Treatment Market Size by Type
8.2.1 Asia-Pacific Central Nervous System Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Central Nervous System Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Central Nervous System Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Central Nervous System Treatment Market Size by Application
8.3.1 Asia-Pacific Central Nervous System Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Central Nervous System Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Central Nervous System Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Central Nervous System Treatment Market Size by Region
8.4.1 Asia-Pacific Central Nervous System Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Central Nervous System Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Central Nervous System Treatment Market Size (2016-2027)
9.2 Latin America Central Nervous System Treatment Market Size by Type
9.2.1 Latin America Central Nervous System Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Central Nervous System Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Central Nervous System Treatment Market Size by Type (2016-2027)
9.3 Latin America Central Nervous System Treatment Market Size by Application
9.3.1 Latin America Central Nervous System Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Central Nervous System Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Central Nervous System Treatment Market Size by Application (2016-2027)
9.4 Latin America Central Nervous System Treatment Market Size by Country
9.4.1 Latin America Central Nervous System Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Central Nervous System Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System Treatment Market Size (2016-2027)
10.2 Middle East & Africa Central Nervous System Treatment Market Size by Type
10.2.1 Middle East & Africa Central Nervous System Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Central Nervous System Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Central Nervous System Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Central Nervous System Treatment Market Size by Application
10.3.1 Middle East & Africa Central Nervous System Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Central Nervous System Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Central Nervous System Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Central Nervous System Treatment Market Size by Country
10.4.1 Middle East & Africa Central Nervous System Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Central Nervous System Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Central Nervous System Treatment Introduction
11.1.4 Biogen Revenue in Central Nervous System Treatment Business (2016-2021)
11.1.5 Biogen Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Central Nervous System Treatment Introduction
11.2.4 Pfizer Revenue in Central Nervous System Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Central Nervous System Treatment Introduction
11.3.4 Teva Revenue in Central Nervous System Treatment Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Central Nervous System Treatment Introduction
11.4.4 Novartis Revenue in Central Nervous System Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Central Nervous System Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Central Nervous System Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 EliLilly
11.6.1 EliLilly Company Details
11.6.2 EliLilly Business Overview
11.6.3 EliLilly Central Nervous System Treatment Introduction
11.6.4 EliLilly Revenue in Central Nervous System Treatment Business (2016-2021)
11.6.5 EliLilly Recent Development
11.7 Otsuka
11.7.1 Otsuka Company Details
11.7.2 Otsuka Business Overview
11.7.3 Otsuka Central Nervous System Treatment Introduction
11.7.4 Otsuka Revenue in Central Nervous System Treatment Business (2016-2021)
11.7.5 Otsuka Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Central Nervous System Treatment Introduction
11.8.4 Merck Revenue in Central Nervous System Treatment Business (2016-2021)
11.8.5 Merck Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Central Nervous System Treatment Introduction
11.9.4 AstraZeneca Revenue in Central Nervous System Treatment Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Central Nervous System Treatment Introduction
11.10.4 Novartis Revenue in Central Nervous System Treatment Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 Takeda
11.11.1 Takeda Company Details
11.11.2 Takeda Business Overview
11.11.3 Takeda Central Nervous System Treatment Introduction
11.11.4 Takeda Revenue in Central Nervous System Treatment Business (2016-2021)
11.11.5 Takeda Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Central Nervous System Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global Central Nervous System Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Central Nervous System Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Central Nervous System Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Central Nervous System Treatment Market Share by Regions (2016-2021)
Table 8. Global Central Nervous System Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Central Nervous System Treatment Market Share by Regions (2022-2027)
Table 10. Central Nervous System Treatment Market Trends
Table 11. Central Nervous System Treatment Market Drivers
Table 12. Central Nervous System Treatment Market Challenges
Table 13. Central Nervous System Treatment Market Restraints
Table 14. Global Central Nervous System Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Central Nervous System Treatment Market Share by Players (2016-2021)
Table 16. Global Top Central Nervous System Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System Treatment as of 2020)
Table 17. Ranking of Global Top Central Nervous System Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Central Nervous System Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Central Nervous System Treatment Product Solution and Service
Table 21. Date of Enter into Central Nervous System Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Central Nervous System Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Central Nervous System Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Central Nervous System Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Central Nervous System Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Central Nervous System Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Central Nervous System Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Central Nervous System Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Central Nervous System Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Central Nervous System Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Central Nervous System Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Central Nervous System Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Central Nervous System Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Central Nervous System Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Central Nervous System Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Central Nervous System Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Central Nervous System Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Central Nervous System Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Central Nervous System Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Central Nervous System Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Central Nervous System Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Central Nervous System Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Central Nervous System Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Central Nervous System Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Central Nervous System Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Central Nervous System Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Central Nervous System Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Central Nervous System Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Central Nervous System Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Central Nervous System Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Central Nervous System Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Central Nervous System Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Central Nervous System Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Central Nervous System Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Central Nervous System Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Central Nervous System Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Central Nervous System Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Central Nervous System Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Central Nervous System Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biogen Company Details
Table 62. Biogen Business Overview
Table 63. Biogen Central Nervous System Treatment Product
Table 64. Biogen Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 65. Biogen Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Central Nervous System Treatment Product
Table 69. Pfizer Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Central Nervous System Treatment Product
Table 74. Teva Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Central Nervous System Treatment Product
Table 79. Novartis Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Central Nervous System Treatment Product
Table 84. Johnson & Johnson Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. EliLilly Company Details
Table 87. EliLilly Business Overview
Table 88. EliLilly Central Nervous System Treatment Product
Table 89. EliLilly Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 90. EliLilly Recent Development
Table 91. Otsuka Company Details
Table 92. Otsuka Business Overview
Table 93. Otsuka Central Nervous System Treatment Product
Table 94. Otsuka Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 95. Otsuka Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. AstraZeneca Company Details
Table 101. AstraZeneca Business Overview
Table 102. AstraZeneca Central Nervous System Treatment Product
Table 103. AstraZeneca Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 104. AstraZeneca Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Central Nervous System Treatment Product
Table 108. Novartis Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 109. Novartis Recent Development
Table 110. Takeda Company Details
Table 111. Takeda Business Overview
Table 112. Takeda Central Nervous System Treatment Product
Table 113. Takeda Revenue in Central Nervous System Treatment Business (2016-2021) & (US$ Million)
Table 114. Takeda Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System Treatment Market Share by Type: 2020 VS 2027
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Central Nervous System Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Central Nervous System Treatment Report Years Considered
Figure 8. Global Central Nervous System Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Central Nervous System Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Central Nervous System Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Central Nervous System Treatment Market Share by Regions (2022-2027)
Figure 12. Global Central Nervous System Treatment Market Share by Players in 2020
Figure 13. Global Top Central Nervous System Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Central Nervous System Treatment Revenue in 2020
Figure 15. Global Central Nervous System Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Central Nervous System Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Central Nervous System Treatment Market Share by Type (2016-2027)
Figure 19. North America Central Nervous System Treatment Market Share by Application (2016-2027)
Figure 20. North America Central Nervous System Treatment Market Share by Country (2016-2027)
Figure 21. United States Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Central Nervous System Treatment Market Share by Type (2016-2027)
Figure 25. Europe Central Nervous System Treatment Market Share by Application (2016-2027)
Figure 26. Europe Central Nervous System Treatment Market Share by Country (2016-2027)
Figure 27. Germany Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Central Nervous System Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Central Nervous System Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Central Nervous System Treatment Market Share by Region (2016-2027)
Figure 37. China Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Central Nervous System Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Central Nervous System Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Central Nervous System Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Central Nervous System Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Central Nervous System Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Central Nervous System Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Central Nervous System Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Biogen Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 57. Pfizer Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 58. Teva Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 61. EliLilly Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 62. Otsuka Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in Central Nervous System Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---